Retraction notice to “RETRACTED: 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors” (Toxicology (2013) 304 (109–119) (S0300483X12004301) (10.1016/j.tox.2012.12.011);6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors

Toxicology

Volumn 304, Issue , 2013, Pages 109-119

  Tobón Velasco, Julio C ^a,b   Limón Pacheco, Jorge H ^a,b   Orozco Ibarra, Marisol ^a   Macías Silva, Marina ^c   Vázquez Victorio, Genaro ^c   Cuevas, Elvis ^d   Ali, Syed F ^d   Cuadrado, Antonio ^e   Pedraza Chaverrí, José ^b   Santamaría, Abel ^a,d  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^e INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

6 Hydroxydopamine; Apoptosis; Kinases signaling; Mitochondrial dysfunction; Nrf2 NF B pathways

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 9; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDOPAMINE; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; INTRACELLULAR SIGNALING; MALE; MOLECULAR INTERACTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION;

EID: 84872591393     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2017.10.001     Document Type: Erratum

References (48)

1. Andreadi C.K., Howells L.M., Atherfold P.A., Manson M.M. Involvement of Nrf2, p38, B-Raf, and nuclear factor-κB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol. Pharmacol. 2006, 69:1033-1040.
2. Andrew R., Watson D.G., Best S.A., Midgley J.M., Wenlong H., Petty R.K. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem. Res. 1993, 18:1175-1177.
3. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Program Neurobiol. 2001, 65:135-172.
4. Bové J., Perier C. Neurotoxin-based models of Parkinson's disease. Neuroscience 2012, 211:51-76.
5. Brown G.C., Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 2004, 1658:44-49.
6. Cano-Ramírez D., Torres-Vargas C.E., Guerrero-Castillo S., Uribe-Carvajal S., Hernández-Pando R., Pedraza-Chaverri J., Orozco-Ibarra M. Effect of glycolysis inhibition on mitochondrial function in rat brain. J. Biochem. Mol. Toxicol. 2012, 26:206-211.
7. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 1999, 57:86-94.
8. Cohen G. Oxidative stress, mitochondrial respiration, and Parkinson's disease. Ann. N Y Acad. Sci. 2000, 899:112-120.
9. Cohen G., Heikkila R.E. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 1974, 249:2447-2452.
10. Deshmukh M., Kuida K., Johnson E.M. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J. Cell Biol. 2000, 150:131-143.
11. Dodel R.C., Du Y., Bales K.R., Ling Z., Carvey P.M., Paul S.M. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res. Mol. Brain Res. 1999, 64:141-148.
12. Elkon H., Melamed E., Offen D. Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J. Mol. Neurosci. 2004, 24:387-400.
13. Fiskum G., Starkov A., Polster B.M., Chinopoulos C. Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann. N Y Acad. Sci. 2003, 991:111-119.
14. Glinka Y., Gassen M., Youdim M.B. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural Transm. Suppl. 1997, 50:55-66.
15. Glinka Y., Tipton K.F., Youdim M.B. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 1996, 66:2004-2010.
16. Glinka Y., Tipton K.F., Youdim M.B. Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur. J. Pharmacol. 1998, 351:121-129.
17. Glinka Y.Y., Youdim M.B. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 1995, 292:329-332.
18. Hanrott K., Murray T.K., Orfali Z., Ward M., Finlay C., O'Neill M.J., Wonnacott S. Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions. Eur. J. Neurosci. 2008, 27:1086-1096.
19. Henchcliffe C., Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 2008, 4:600-609.
20. Holtz W.A., Turetzky J.M., O'Malley K.L. Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. Antioxid. Redox Signal. 2005, 7:639-648.
21. Iglesias-Gonzalez J., Sanchez-Iglesias S., Mendez-Alvarez E., Rose S., Hikima A., Jenner P., Soto-Otero R. Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase. Neurochem. Res. 2012, 37:2150-2160.
22. Jordan J., Galindo M.F., Tornero D., Gonzalez-Garcia C., Ceña V. Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. J. Neurochem. 2004, 89:124-133.
23. Kanthasamy A., Jin H., Mehrotra S., Mishra R., Kanthasamy A., Rana A. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease. Neurotoxicology 2010, 31:555-561.
24. Kim-Han J.S., O'Malley K.L. Cell stress induced by the parkinsonian mimetic, 6-hydroxydopamine, is concurrent with oxidation of the chaperone, ERp57, and aggresome formation. Antioxid. Redox Signal. 2007, 9:2255-2264.
25. Khodagholi F., Tusi S.K. Stabilization of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells. Mol. Cell Biochem. 2011, 354:97-112.
26. Krohn A.J., Wahlbrink T., Prehn J.H. Mitochondrial depolarization is not required for neuronal apoptosis. J. Neurosci. 1999, 19:7394-7404.
27. 2 modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes. Free Radic. Biol. Med. 2012, 52:1067-1074.
28. Linert W., Herlinger E., Jameson R.F., Kienzl E., Jellinger K., Youdim M.B. Dopamine, 6-hydroxydopamine, iron, and dioxygen-their mutual interactions and possible implication in the development of Parkinson's disease. Biochim. Biophys. Acta 1996, 1316:160-168.
29. Long J., Ma J., Luo C., Mo X., Sun L., Zang W., Liu J. Comparison of two methods for assaying complex I activity in mitochondria isolated from rat liver, brain and heart. Life Sci. 2009, 85:276-280.
30. Lotharius J., Dugan L.L., O'Malley K.L. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 1999, 19:1284-1293.
31. Lowry O.H., Rosebrough N.J., Farr A.L., Randal R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
32. Miller R.L., James-Kracke M., Sun G.Y., Sun A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 2009, 34:55-65.
33. Mirandola S.R., Melo D.R., Saito A., Castilho R.F. 3-Nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions. J. Neurosci. Res. 2010, 88:630-639.
34. Naoi M., Maruyama W., Yi H., Inaba K., Akao Y., Shamoto-Nagai M. Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. J. Neural Transm. 2009, 116:1371-1381.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, San Diego.
36. Saito Y., Nishio K., Ogawa Y., Kinumi T., Yoshida Y., Masuo Y., Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic. Biol. Med. 2007, 42:675-685.
37. Smigrodzki R., Parks J., Parker W.D. High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol. Aging 2004, 25:1273-1281.
38. Stefanis L., Park D.S., Friedman W.J., Greene L.A. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J. Neurosci. 1999, 19:6235-6247.
39. Storch A., Kaftan A., Burkhardt K., Schwarz J. 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism. J. Neural Transm. 2000, 107:281-293.
40. Tarabin V., Schwaninger M. The role of NF-κB in 6-hydroxydopamine- and TNFα-induced apoptosis of PC12 cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 2004, 369:563-569.
41. Tobón-Velasco J.C., Carmona-Aparicio L., Ali S.F., Santamaría A. Biomarkers of cell damage induced by oxidative stress in Parkinson's disease and related models. Cent. Nerv. Syst. Agents Med. Chem. 2010, 10:278-286.
42. Tobón-Velasco J.C., Vazquez-Victorio G., Macias-Silva M., Cuevas E., Ali S.F., Maldonado P.D., González-Trujano M.E., Cuadrado A., Pedraza-Chaverrí J., Santamaría A. S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades. Free Radic. Biol. Med. 2012, 53:1024-1040.
43. Tsang A.H., Chung K.K. Oxidative and nitrosative stress in Parkinson's disease. Biochim. Biophys. Acta 2009, 1792:643-650.
44. Tusi S.K., Ansari N., Amini M., Amirabad A.D., Shafiee A., Khodagholi F. Attenuation of NF-κB and activation of Nrf2 signaling by 1,2,4-triazine derivatives, protects neuron-like PC12 cells against apoptosis. Apoptosis 2010, 15:738-751.
45. Wigdal S.S., Kirkland R.A., Franklin J.L., Haak-Frendscho M. Cytochrome c release precedes mitochondrial membrane potential loss in cerebellar granule neuron apoptosis: lack of mitochondrial swelling. J. Neurochem. 2002, 82:1029-1038.
46. Yuyama K., Yamamoto H., Nishizaki I., Kato T., Sora I., Yamamoto T. Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome c oxidase inhibition and the production of reactive oxygen species in mitochondria. J. Neurosci. Res. 2003, 73:351-363.
47. Zhou J., Tang X.C. Huperzine A attenuates apoptosis and mitochondria-dependent caspase-3 in rat cortical neurons. FEBS Lett. 2002, 526:21-25.
48. Zhou F., Wu J.Y., Sun X.L., Yao H.H., Ding J.H., Hu G. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation. Neuropsychopharmacology 2007, 32:2570-2580.